Background and Objective: Bronchiectasis, which was previously regarded as a rare condition, has recently attracted increased attention with advancements in research and therapeutic strategies.

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies geographically. Large trials are needed to assess safety and effectiveness. For ...

Bronchiectasis is a long-term health condition in which airways are constantly irritated or inflamed, leading to permanent airway damage and a buildup of mucus. This often causes a chronic cough and ...

RUPTURE of one of the major bronchi is now regarded as a relatively frequent complication of severe closed thoracic trauma. 1 Although the common complications of this type of injury, including ...

The presence of a positive fungal culture in patients with bronchiectasis does not appear to correlate with disease severity or any increased risk of an adverse outcome, according to data pulled from ...

The lung disease bronchiectasis plays out as a vicious cycle. Infection leads to inflammation followed by the impaired ability to clear the excess mucus coughed up from the lungs. These problems lead ...

Please provide your email address to receive an email when new articles are posted on . Treatment with brensocatib for 24 weeks significantly prolonged time to first pulmonary exacerbation in patients ...

An international research team has found that patients with the lung disease bronchiectasis also often display sensitivity to airborne allergens, and has highlighted the particular role that fungi ...

BRIDGEWATER, N.J., Sept. 7, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...

If you have bronchiectasis, the essential goal of treatment is to keep your airway clear. Bronchiectasis is a chronic lung condition in which the airways become widened and damaged, making it harder ...